Dorsomorphin 2HCl (BML-275, Compound C) is a potent, reversible, selective AMPK inhibitor with Ki of 109 nM in cell-free assays, exhibiting no significant inhibition of several structurally related kinases including ZAPK, SYK, PKCθ, PKA, and JAK3. Also inhibits type Ⅰ BMP receptor activity. Dorsomorphin induces autophagy in cancer cell line.
AMPK Inhibitors Related Prodcuts:
Dorsomorphin (Compound C); WZ4003; ON123300; Doxorubicin HCl; GSK690693; MK-3903